← Back to Divis Laboratories Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

DIVISLABPharmaceuticals

Divis Laboratories Ltd — Financial Ratios & Key Metrics

₹5947.00

-1.42%

P/E Ratio68.59xIndustry: 31.77x

ROE15.35%Return on equity

ROCE20.44%Return on capital

Debt/Equity0.01Low debt

💎

Valuation & Profitability

P/E Ratio

68.59x

Industry Average P/E

31.77x

Dividend Yield

0.47%

Market Cap

₹1.70L (Cr)

Sales Growth 5Y

11.65%

Profit Growth 5Y

10.41%

EPS Growth 5Y

10.41%

OPM 5Y Avg

34.98%

📉

Price Returns

1 Month

-4.68%

3 Months

+4.93%

6 Months

-2.95%

1 Year

+4.05%

52W Low

₹4955

Current

₹5947

52W High

₹7072

47% of 52-week range — Mid range

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹6189

▼ Price below SMA 50 — Bearish

SMA 200

₹6359

▼ Long-term downtrend

Volume Signal

186% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Divis Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.